Key result
Porcine mitral bioprostheses linked to ~11-point lower 15-year reintervention risk vs bovine valves.
Its licence doesn't allow us to show a copy here.
Why the study?
The comparative durability of bovine pericardial versus porcine bioprostheses in surgical mitral valve replacement was not well established.
Does a porcine bioprosthesis improve durability and reduce structural valve deterioration compared to a bovine bioprosthesis in adults undergoing surgical mitral valve replacement?
Cohort (n=6,515)
Does a porcine bioprosthesis improve durability and reduce structural valve deterioration compared to a bovine bioprosthesis in adults undergoing surgical mitral valve replacement?
Absolute Event Rate: 34% vs 45%
p-value: p=late P=.003
Porcine stented bioprostheses in the mitral position demonstrate significantly lower rates of structural valve deterioration and better late durability compared to bovine bioprostheses.
Porcine valves were associated with lower SVD reoperation; leaves open optimal mitral prosthesis selection pending randomized data.
OBJECTIVE: The objective of this study was to compare the durability of bovine pericardial and porcine bioprostheses in patients who underwent surgical mitral valve replacement. METHODS: From 1/1/2000-1/1/2024, 6,515 adults underwent 6,789 mitral valve replacements with either porcine(n=4,597) or bovine(n=2,192) stented bioprostheses. Propensity score matching yielded 1,853 well-matched pairs. Durability was assessed by explant for structural valve deterioration(SVD) and longitudinal analysis of echocardiographic data(≥moderate mitral regurgitation and mean mitral gradient). Mortality and competing risks of explant for SVD and infective endocarditis were modeled using multiphase hazards. RESULTS: Bovine bioprostheses were more commonly used before 2010, and porcine more recently. Within the matched groups, 352 reinterventions were identified, primarily for SVD(70%; n=253) and endocarditis(19%; n=69). At 15 years, conditional probability of reintervention for SVD was 34% in the porcine versus 45% in the bovine group(early P=.61; late P=.003). The porcine group had an increased risk of reintervention for endocarditis in the first year(P=.046), but similar risk thereafter(P=.54). Risk of ≥moderate mitral regurgitation at 10 years was 3% among porcine and 12% among bovine bioprostheses(P<.0001), with higher mean gradients in the bovine group(6.6 mmHg vs. 8.2 mmHg; late P<.0001). Survival 15-years after porcine mitral valve replacement was 18%, compared to 22% after bovine(P=.21). CONCLUSIONS: The stent-mounted porcine bioprosthesis had better durability than the bovine bioprosthesis in the mitral position and is preferred over a bovine bioprosthesis with excellent late outcomes, particularly in patients under 60 years of age.
No takes yet. Share an insight, caveat, or question.
Malas et al. (2026) conducted a cohort in Surgical mitral valve replacement (n=6,515). Porcine bioprosthesis vs. Bovine bioprosthesis was evaluated on Conditional probability of reintervention for structural valve deterioration at 15 years (p=late P=.003). Porcine mitral valve bioprostheses had a lower 15-year probability of reintervention for structural valve deterioration than bovine bioprostheses (34% vs 45%; late P=0.003).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: